Type 2 Diabetes

>

Latest News

Manufacturing Costs for Diabetes Medicines Could Likely Be Lower | Image Credit: Harvard University
Manufacturing Costs for Diabetes Medicines Could Likely Be Lower, Study Finds

April 4th 2024

Prices of nearly all insulins, SGLT2 inhibitors, and GLP1As could be reduced if robust generic or biosimilar manufacture were enabled.

Endocrinology Month in Review: March 2024 thumbnail featuring HCOLive endocrinology logo
Endocrinology Month in Review: March 2024

April 3rd 2024

Credit: US Food and Drug Administration
Semaglutide (Wegovy) Receives FDA Label Expansion to Include Cardiovascular Risk Reduction

March 8th 2024

Stock imagery of a body weight scale. | Credit: iStock
Novo Nordisk Delivers Updates on Development of Semaglutide, CagriSema, Amycretin, and More

March 7th 2024

Endocrinology month in review February 2024 thumbnail
Endocrinology Month in Review: February 2024

March 6th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.